Skip to main content
. 2010 Oct 16;21(2):122–133. doi: 10.1007/s10165-010-0366-7

Fig. 4.

Fig. 4

Kaplan–Meier curve of the retention rate of tocilizumab therapy. a Tocilizumab retention rate in all 229 cases. b Tocilizumab retention rates by cause of discontinuation. c Tocilizumab retention rates in patients who did (n = 127) and did not (n = 102) receive concomitant MTX. d Tocilizumab retention rates in patients who did (n = 144) and did not (n = 85) previously receive anti-TNF therapy